Literature DB >> 9365891

Detection of hepatitis C virus genomic sequences in the cerebrospinal fluid of HIV-infected patients.

G Morsica1, M T Bernardi, R Novati, C Uberti Foppa, A Castagna, A Lazzarin.   

Abstract

To assess the presence of hepatitis C virus (HCV) in the central nervous system (CNS), HCV-RNA was sought in paired serum and cerebrospinal fluid (CSF) samples of 21 HIV/HCV-positive patients: HCV-RNA was detected in the serum of 19/21 patients (90.4%), and in the CSF of five of the 19 serum-positive patients. The presence of HCV-RNA was confirmed in follow-up CSF samples available for three of these five patients. An identical HCV genotype was found in the paired serum/CSF samples. No correlation was found between the different genotypes and the presence of HCV in CSF of the individual patients. HCV viremia levels measured by branched-DNA and quantitative PCR were not significantly higher in the CSF-positive cases than in the CSF-negative cases (P = 0.3, using b-DNA; 0.5, using quantitative PCR). This report shows the presence of HCV in CSF and raises the possibility that the CNS may act as a reservoir site for HCV.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9365891     DOI: 10.1002/(sici)1096-9071(199711)53:3<252::aid-jmv12>3.0.co;2-j

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  11 in total

1.  Is there a direct role of hepatitis C virus in portosystemic encephalopathy?

Authors:  Giovanni Tarantino
Journal:  J Gastroenterol       Date:  2008-03-29       Impact factor: 7.527

Review 2.  Molecular targets of opiate drug abuse in neuroAIDS.

Authors:  K F Hauser; N El-Hage; S Buch; J R Berger; W R Tyor; A Nath; A J Bruce-Keller; P E Knapp
Journal:  Neurotox Res       Date:  2005-10       Impact factor: 3.911

3.  Neurobehavioral effects of interferon-α in patients with hepatitis-C: symptom dimensions and responsiveness to paroxetine.

Authors:  Marcia D McNutt; Shuling Liu; Amita Manatunga; Erica B Royster; Charles L Raison; Bobbi J Woolwine; Marina F Demetrashvili; Andrew H Miller; Dominique L Musselman
Journal:  Neuropsychopharmacology       Date:  2012-02-22       Impact factor: 7.853

4.  Acute myelitis associated with HCV infection.

Authors:  Kentaro Suzuki; Masaki Takao; Yasuo Katayama; Ban Mihara
Journal:  BMJ Case Rep       Date:  2013-06-13

Review 5.  Cognitive dysfunction in chronic hepatitis C: a review.

Authors:  William Perry; Robin C Hilsabeck; Tarek I Hassanein
Journal:  Dig Dis Sci       Date:  2007-08-17       Impact factor: 3.199

6.  The cognitive effects of hepatitis C in the presence and absence of a history of substance use disorder.

Authors:  Marilyn Huckans; Adriana Seelye; Tiffany Parcel; Lisa Mull; Jonathan Woodhouse; Danell Bjornson; Bret E Fuller; Jennifer M Loftis; Benjamin J Morasco; Anna W Sasaki; Daniel Storzbach; Peter Hauser
Journal:  J Int Neuropsychol Soc       Date:  2009-01       Impact factor: 2.892

7.  Clinicopathologic correlates of hepatitis C virus in brain: a pilot study.

Authors:  Jacinta Murray; Sarah L Fishman; Elizabeth Ryan; Francis J Eng; José L Walewski; Andrea D Branch; Susan Morgello
Journal:  J Neurovirol       Date:  2008-01       Impact factor: 2.643

8.  Brain Microstructural Correlates of Cognitive Dysfunction in Clinically and Biochemically Normal Hepatitis C Virus Infection.

Authors:  Ajay Kumar; Amar Deep; Rakesh K Gupta; Virendra Atam; Samir Mohindra
Journal:  J Clin Exp Hepatol       Date:  2017-04-04

9.  Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication.

Authors:  Marek Radkowski; Jeffrey Wilkinson; Marek Nowicki; Debra Adair; Hugo Vargas; Craig Ingui; Jorge Rakela; Tomasz Laskus
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

10.  Cell culture-derived HCV cannot infect synovial fibroblasts.

Authors:  Abd-Elshafy D Nadeem; Pietschmann Thomas; Müller-Ladner Ulf; Neumann Elena; A Anggakusuma; Bahgat M Mohamed; Pessler Frank; Behrendt Patrick
Journal:  Sci Rep       Date:  2015-12-08       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.